ORIC
ORIC
NASDAQ · Biotechnology

Oric Pharmaceuticals Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks
$8.92
-0.38 (-4.09%)
As of May 9, 1:38 AM ET ·
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Buy 19 90%
Hold 2 10%
Sell 0 0%
Price Target
Analyst Price Target +485.9% upside
Low Target $31.55
Average Target $52.26
High Target $71.26
Current Price $8.92
Current
$8.92
Target
$52.26
$31.55 $52.26 avg $71.26
Scenario Analysis
Bear Case
$31.55
253.7%
Low target
Base Case
$52.26
+485.9%
Avg target
Bull Case
$71.26
+698.9%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$14.93
-40.3% from high
52-Week Low
$4.52
+97.3% from low
Target vs 52W High
$52.26
+250.0% vs high
Next Earnings Report
May 11, 2026
Today
EPS Est: $-0.33
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%